Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study

被引:0
|
作者
Cho-Han Chiang
Yuan-Jen Chen
Cho-Hsien Chiang
Cheng-Ying Chen
Yu-Cheng Chang
Shih-Syuan Wang
Xin Ya See
Chuan-Sheng Horng
Chun-Yu Peng
Yuan Ping Hsia
Cheng-Ming Peng
Cho-Hung Chiang
机构
[1] Mount Auburn Hospital,Department of Medicine
[2] Harvard Medical School,Department of Medicine
[3] Taipei Veterans General Hospital,Department of Medical Education
[4] Kuang Tien General Hospital,Department of Medical Education
[5] Cathay General Hospital,Da Vinci Minimally Invasive Surgery Center
[6] Chung Shan Medical University Hospital,Department of Medicine
[7] Unity Hospital,Department of Internal Medicine
[8] Rochester Regional Health,Department of Medicine
[9] Chung Shan Medical University Hospital,Department of Family Medicine, Taipei Tzu Chi Hospital
[10] Danbury Hospital,Department of Medicine, School of Medicine
[11] Buddhist Tzu Chi Medical Foundation,Department of Internal Medicine
[12] Chung Shan Medical University,Department of General Division, Taipei Tzu Chi Hospital
[13] National Taiwan University Hospital,undefined
[14] Buddhist Tzu Chi Medical Foundation,undefined
来源
关键词
Immune checkpoint inhibitors; Immunotherapy; Metformin; Drug re-purposing; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1951 / 1956
页数:5
相关论文
共 50 条
  • [21] Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
    Khalil, Lana
    Kang, Sandra
    McCook-Veal, Ashley
    Draper, Amber
    Diab, Maria
    Shaib, Walid Labib
    Alese, Olatunji B.
    El-Rayes, Bassel F.
    Akce, Mehmet
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study
    Ikoma, Tatsuki
    Matsumoto, Toshihiko
    Boku, Shogen
    Motoki, Yusuke
    Kinoshita, Hidefumi
    Kosaka, Hisashi
    Kaibori, Masaki
    Inoue, Kentaro
    Sekimoto, Mitsugu
    Fujisawa, Takuo
    Iwai, Hiroshi
    Naganuma, Makoto
    Tanizaki, Hideaki
    Hisamatsu, Yoji
    Okada, Hidetaka
    Kurata, Takayasu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (07)
  • [23] Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study
    Raghavan, Arjun
    Goutam, Sid
    Musto, Grace
    Geirnaert, Marc
    Ye, Carrie
    O'Neil, Liam
    Graham, Jeffrey
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (01) : 1 - 6
  • [24] Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort study
    Gupta, Mehul
    Stukalin, Igor
    Meyers, Daniel E.
    Heng, Daniel Y. C.
    Monzon, Jose
    Cheng, Tina
    Navani, Vishal
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [25] Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
    Tiu, Bruce C.
    Strohbehn, Ian A.
    Zhao, Sophia
    Ouyang, Tianqi
    Hanna, Paul
    Wang, Qiyu
    Gupta, Shruti
    Leaf, David E.
    Reynolds, Kerry L.
    Sise, Meghan E.
    ONCOLOGIST, 2023, 28 (06): : E379 - E390
  • [26] Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: A retrospective observational cohort study
    Gupta, Mehul
    Stukalin, Igor
    Goutam, Siddhartha
    Meyers, Daniel E.
    Heng, Daniel Yick Chin
    Cheng, Tina
    Monzon, Jose Gerard
    Navani, Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors
    Shen, Jinhai
    Ye, Xinqi
    Hou, Hui
    Wang, Yun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [28] Efficacy of lipophilic statins on outcomes of patients treated with immune checkpoint inhibitors
    Chiang, Cho-Han
    Chen, Yuan-Jen
    See, Xin Ya
    Chang, Yu-Cheng
    Wang, Shih-Syuan
    Peng, Chun-Yu
    Horng, Chuan-Sheng
    Hsia, Yuan Ping
    Chiang, Cho-Hung
    Peng, Cheng-Ming
    Chiang, Cho-Hsien
    ONCOLOGY, 2023, 101 (09) : 537 - 541
  • [29] ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study
    Iivanainen, Sanna
    Alanko, Tuomo
    Peltola, Katriina
    Konkola, Teemu
    Ekstroem, Jussi
    Virtanen, Henri
    Koivunen, Jussi P.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (03) : 765 - 774
  • [30] Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping review
    Guven, Deniz Can
    Thong, Melissa S. Y.
    Arndt, Volker
    JOURNAL OF CANCER SURVIVORSHIP, 2024,